Life Edit Therapeutics
Karthik Tiruthani is an accomplished scientist specializing in protein engineering and virology, currently serving as Scientist II at Life Edit Therapeutics since March 2022. Prior experience includes work as a Virology Scientist at Istari Oncology, where responsibilities encompassed GMP lab techniques and the development of analytical assays for viral research. Karthik's research at the University of North Carolina at Chapel Hill focused on creating neutralizing antibodies against SARS-CoV-2 and respiratory viruses, contributing to clinical trials and preclinical advancements, while also holding a postdoctoral position that involved innovative antibody engineering. Early career experience includes roles at North Carolina State University involving biosensor development and teaching assistance, along with internships and project engineering work in industry settings. Karthik holds a PhD in Chemical and Biomolecular Engineering and a Master's degree in Mechanical Engineering from North Carolina State University, as well as a Bachelor's degree in Mechatronics from Jawaharlal Nehru Technological University.
Life Edit Therapeutics
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.